SMI 9'353 -0.1%  Dow 18'232 -0.3%  Nikkei 20'264 0.3%  Euro 1.0391 -0.1% 
SPI 9'492 -0.1%  EStoxx50 3'679 -0.3%  Gold 1'206 0.0%  Dollar 0.9438 0.0% 
DAX 11'815 -0.4%  FTSE100 7'032 0.3%  Öl 65.5 -1.4%  Pfund 1.4457 -1.5% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

27.03.15 Biomarin Pharmaceutical Buy UBS AG
27.03.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
29.10.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.09.08 Biomarin Pharmaceutical outperform William Blair
27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
22.05.15 Foot Locker Outperform Telsey Advisory Group
22.05.15 ANN Neutral Mizuho
22.05.15 Vossloh buy S&P Capital IQ
22.05.15 Best Buy Buy Deutsche Bank AG
22.05.15 The JG Wentworth Company (A) Hold Deutsche Bank AG
22.05.15 Mednax Buy Dougherty & Company LLC
22.05.15 Open Text overweight Barclays Capital
22.05.15 Intuit Equal weight Barclays Capital
22.05.15 Booz Allen Hamilton a overweight Barclays Capital
22.05.15 BHP Billiton Market Perform BMO Capital Markets
22.05.15 Norwegian Cruise Line Buy UBS AG
22.05.15 AutoZone Neutral UBS AG
22.05.15 Ross Stores Neutral UBS AG
22.05.15 Aeropostale Neutral UBS AG
22.05.15 Intuit Buy UBS AG
22.05.15 Zurich Insurance Group Verkaufen DZ-Bank AG
22.05.15 INDUS Hold Independent Research GmbH
22.05.15 MLP Halten Independent Research GmbH
22.05.15 Südzucker Verkaufen Independent Research GmbH
22.05.15 Bauer Halten Independent Research GmbH
22.05.15 Urban Outfitters Neutral UBS AG
22.05.15 ANN Neutral UBS AG
22.05.15 Akamai Technologies Buy UBS AG
22.05.15 GlaxoSmithKline Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.05.15 STADA Arzneimittel Halten DZ-Bank AG
22.05.15 Brenntag Halten Norddeutsche Landesbank (Nord/LB)
22.05.15 Rheinmetall Sell S&P Capital IQ
22.05.15 Ross Stores Neutral MKM Partners
22.05.15 Marvell Technology Group Buy MKM Partners
22.05.15 RTL Group Halten Norddeutsche Landesbank (Nord/LB)
22.05.15 Berkshire Hills Bancorp Neutral Compass Point
22.05.15 HORNBACH vz Hold DZ-Bank AG
22.05.15 Talanx Hold Commerzbank AG
22.05.15 HOCHTIEF Hold Commerzbank AG
22.05.15 Richemont Hold S&P Capital IQ
22.05.15 Air France-KLM neutral S&P Capital IQ
22.05.15 VTG kaufen Norddeutsche Landesbank (Nord/LB)
22.05.15 Südzucker buy Kepler Cheuvreux
22.05.15 Stabilus SA buy Kepler Cheuvreux
22.05.15 Wincor Nixdorf verkaufen Kepler Cheuvreux
22.05.15 KUKA Reduce Kepler Cheuvreux
22.05.15 BNP Paribas Hold Jefferies & Company Inc.
22.05.15 Société Générale SA Underperform Jefferies & Company Inc.
22.05.15 Repsol Neutral JP Morgan Chase & Co.
22.05.15 Eni Neutral JP Morgan Chase & Co.
22.05.15 TOTAL overweight JP Morgan Chase & Co.
22.05.15 Synergy Pharmaceuticals Buy Canaccord Adams
22.05.15 ReWalk Robotics Buy Canaccord Adams
22.05.15 BP Neutral JP Morgan Chase & Co.
22.05.15 Capital Stage buy Warburg Research